Treatment of Neurogenic Detrusor Overactivity with Botulinum Toxin

Introduction to Botulinum Toxin Therapy

• Botulinum toxin (Botox) is an effective and recommended treatment option for urinary incontinence due to neurogenic detrusor overactivity, particularly in patients with spinal cord injury or multiple sclerosis who are refractory to oral medications 1
• The American Urological Association recommends Botox therapy for patients with neurogenic detrusor overactivity who have failed or cannot tolerate oral medications 1

Patient Selection and Preparation

• Before administering Botox, clinicians must measure post-void residual to establish baseline bladder emptying 2
• Clinicians should discuss specific risks of urinary retention and potential need for intermittent catheterization with patients 1
• Ensure patient capability for clean intermittent catheterization if needed 1

Treatment Administration and Follow-Up

• Evaluate patients approximately 2 weeks after injection to assess symptom improvement, post-void residual to rule out urinary retention, and presence of urinary tract infection if symptoms haven't improved 2
• Consider discontinuing oral medications if good response is achieved 2
• Plan for repeat injections when efficacy diminishes (typically every 9-11 months) is not directly cited but implied through the discussion of treatment duration 2

Advantages and Efficacy of Botox

• Botox offers a more robust evidence base compared to other third-line options for neurogenic detrusor overactivity 1
• Strong recommendation (Grade A evidence) for spinal cord injury and multiple sclerosis patients 1
• Botox avoids permanent surgical alterations like sphincterotomy 1

Adverse Effects

• Urinary retention occurs in 20-54% of neurogenic detrusor overactivity patients receiving Botox (vs 1.9-5.0% with placebo) 1